Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group

Leukemia Research

Volumn 34, Issue 4, 2010, Pages 438-446

  Tsagarakis, Nikolaos J ^a   Kentrou, Nektaria A ^a   Papadimitriou, Konstantinos A ^a   Pagoni, Maria ^b   Kokkini, Garyfallia ^c   Papadaki, Helen ^d   Pappa, Vassiliki ^e   Marinakis, Theodoros ^a   Anagnostopoulos, Nikolaos I ^a   Vadikolia, Chrissanthi ^f   Anagnostopoulos, Achilleas ^f   Angelopoulou, Maria K ^g   Terpos, Evangelos ^h   Poziopoulos, Christos ⁱ   Anargyrou, Konstantinos ^h   Rontogianni, Dimitra ^b   Papadaki, Theodora ^b   Psarra, Aikaterini ^b   Kontopidou, Flora N ^j   Skoumi, Dimitra ^a   Papadhimitriou, Stefanos I ^a   Paterakis, Georgios ^a   more..

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c SISMANOGLIO HOSPITAL   (Greece)

^d UNIVERSITY OF CRETE   (Greece)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^f G PAPANICOLAOU HOSPITAL   (Greece)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^h IASO GENERAL HOSPITAL   (Greece)

ⁱ 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^j LAIKO GENERAL HOSPITAL   (Greece)

more..

Author keywords

Acute leukemia; Blastic plasmacytoid dendritic cell neoplasm; BPDCN; DC2; Hematodermic tumor; Lymphoplasmacytoid leukemia

Indexed keywords

CD123 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; HLA DR ANTIGEN; TUMOR MARKER;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLASTIC PLASMACYTOID DENDRITIC CELL LEUKEMIA; CANCER MORPHOLOGY; CELL POPULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; FLOW CYTOMETRY; GREECE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MYELOID PROGENITOR CELL; PRE T LYMPHOCYTE; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTOGENETIC ANALYSIS; DENDRITIC CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GREECE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 77049102382     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.09.006     Document Type: Article

References (35)

1. O'Doherty U., Peng M., Gezelter S., Swiggard W.J., Betjes M., Bhardwaj N., et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82 (1994) 487-493
2. Thomas R., and Lipsky P.E. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol 153 (1994) 4016-4028
3. Olweus J., BitMansour A., Warnke R., Thomson P.A., Carballido J., Picker L.J., et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 94 (1997) 12551-12556
4. Facchetti F., Vermi W., Mason D., and Colonna M. The plasmacytoid monocyte/interferon producing cells. Virchows Arch 443 6 (2003) 703-717
5. DiGiuseppe J.A., Louie D.C., Williams J.E., Miller D.T., Griffin C.A., Mann R.B., et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol 21 (1997) 1223-1230
6. Kameoka J., Ichinohasama R., Tanaka M., Miura I., Tomiya Y., Takahashi S., et al. A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature. Am J Clin Pathol 110 (1998) 478-488
7. Petrella T., Dalac S., Maynadié M., Mugneret F., Thomine E., Courville P., et al. CD4+CD56+ cutaneous neoplasms: a distinct hematological entity?. Am J Surg Pathol 23 (1999) 137-146
8. Chaperot L., Bendriss N., Manches O., Gressin R., Maynadie M., Trimoreau F., et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 97 (2001) 3210-3217
9. Feuillard J., Jacob M.C., Valensi F., Maynadié M., Gressin R., Chaperot L., et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 99 (2002) 1556-1563
10. Khoury J.D., Medeiros L.J., Manning J.T., Sulak L.E., Bueso-Ramos C., and Jones D. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 94 (2002) 2401-2408
11. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. (2008), International Agency for Research on Cancer, Lyon, France
12. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 May (2005) 3768-3785
13. Bene M.C., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A., et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9 (1995) 1783-1786
14. Anargyrou K., Paterakis G., Boutsis D., Politou M., Papadhimitriou S.I., Siakandaris M., et al. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia. Eur J Haematol 71 (2003) 294-298
15. Leroux D., Mugneret F., Callanan M., Radford-Weiss I., Dastugue N., Feuillard J., et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood 99 (2002) 4154-4159
16. Herling M., and Jones D. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol 127 (2007) 687-700
17. Bueno C., Almeida J., Lucio P., Marco J., Garcia R., de Pablos J.M., et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica 89 (2004) 58-69
18. Petrella T., Wechsler J., Courville P., de Muret A., Bosq J., Déchelotte P., et al. Hematodermic CD4/CD56 neoplasm. Ann Pathol 24 (2004) 241-255
19. Brody J.P., Allen S., Schulman P., Sun T., Chan W.C., Friedman H.D., et al. Acute agranular CD4-positive natural killer cell leukaemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents. Cancer 75 (1995) 2474-2483
20. Gopcsa L., Banyai A., Jakab K., Kormos L., Tamaska J., Matolcsy A., et al. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells. Eur J Haematol 75 (2005) 346-351
21. Petrella T., Bagot M., Willemze R., Beylot-Barry M., Vergier B., Delaunay M., et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 123 (2005) 662-675
22. Rossi J.G., Felice M.S., Bernasconi A.R., Ribas A.E., Gallego M.S., Somardzic A.E., et al. Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome. Leuk Lymphoma 47 (2006) 715-725
23. Reimer P., Rudiger T., Kraemer D., Kunzmann V., Weissinger F., Zettl A., et al. What is CD4+CD56+ malignancy and how should it be treated?. Bone Marrow Transplant 32 (2003) 637-646
24. Bekkenk M.W., Jansen P.M., Meijer C.J., and Willemze R. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 15 (2004) 1097-1108
25. Lacombe F., Durrieu F., Briais A., Dumain P., Belloc F., Bascans E., et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 11 (1997) 1878-1886
26. Garnache-Ottou F., Feuillard J., Ferrand C., Biichle S., Trimoreau F., Seilles E., et al. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol 145 (2009) 624-636
27. Petrella T., Comeau M.R., Maynadié M., Couillault G., De Muret A., Maliszewski C.R., et al. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 26 (2002) 852-862
28. Knapp W., Stockinger H., and Majdic O. Antibody-defined cell surface molecules of the immune system. Curr Opin Immunol 2 (1989-1990) 884-891
29. Jacob M.C., Chaperot L., Mossuz P., Feuillard J., Valensi F., Leroux D., et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 88 (2003) 941-955
30. Béné M.C., Feuillard J., and Jacob M.C. Groupe d'Etude Immunologique des Leucémies. Plasmacytoid dendritic cells: from the plasmacytoid T-cell to type 2 dendritic cells CD4+CD56+ malignancies. Semin Hematol 40 (2003) 257-266
31. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165 (2000) 6037-6046
32. Bayerl M.G., Rakozy C.K., Mohamed A.N., Vo T.D., Long M., Eilender D., et al. Blastic natural killer cell lymphoma/leukemia: a report of seven cases. Am J Clin Pathol 117 (2002) 41-50
33. Uchiyama N., Ito K., Kawai K., Sakamoto F., Takaki M., and Ito M. CD2-, CD41+, CD56+ agranular natural killer cell lymphoma of the skin. Am J Dermatopathol 20 (1998) 513-517
34. Vermi W., Facchetti F., Rosati S., Vergoni F., Rossi E., Festa S., et al. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol 28 (2004) 585-595
35. Mohty M., Jarrossay D., Lafage-Pochitaloff M., Zandotti C., Brière F., de Lamballeri X.N., et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 98 (2001) 3750-3756